Ranking Year:
# | Company Name | Region | Tech Topics | Total |
---|
1 | ![]() | Medicine | Avg patent value: 11.05 M | |
2 | Avg patent value: 11.05 M | |||
3 | Health care,Medicine | Avg patent value: 8.78 M | ||
4 | Metal powder,Metal | Avg patent value: 6.96 M | ||
5 | ![]() | Medicine,Health care,Cancer immunotherapy, ...[+2] | Avg patent value: 6.64 M | |
6 | ![]() | Avg patent value: 6.43 M | ||
7 | ![]() | Gynecology,Companion diagnostic,Therapeutic window, ...[+2] | Avg patent value: 5.84 M | |
8 | ![]() | Medicine,Health care,Pharmacy and Therapeutics, ...[+2] | Avg patent value: 4.87 M | |
9 | Avg patent value: 4.72 M | |||
10 | ![]() | Drug development,Medical therapy,Health care, ...[+2] | Avg patent value: 4.09 M | |
11 | ![]() | Medicine,Health care,Nephropathy, ...[+2] | Avg patent value: 4.09 M | |
12 | ![]() | Small molecule,Medicine,Drug development, ...[+2] | Avg patent value: 3.67 M | |
13 | ![]() | Oncology,Drug,Gene delivery, ...[+2] | Avg patent value: 3.38 M | |
14 | ![]() | Biomarker discovery,Hospitality industry,Medical equipment, ...[+2] | Avg patent value: 2.33 M | |
15 | Molecular diagnostics,Diagnostic test,Medicine, ...[+2] | Avg patent value: 2.03 M | ||
16 | ![]() | Companion diagnostic,Polymerase chain reaction,Vemurafenib, ...[+2] | Avg patent value: 1.68 M | |
17 | ![]() | Messenger RNA,Medicine,Pharmacy and Therapeutics, ...[+2] | Avg patent value: 1.29 M | |
18 | ![]() | Basic research,Publishing,Market research, ...[+2] | Avg patent value: 1.17 M | |
19 | ![]() | Medicine,Nuclear medicine,Andrology, ...[+2] | Avg patent value: 1.08 M | |
20 | ![]() | Molecular diagnostics,Medicine,Health care, ...[+2] | Avg patent value: 930,000 |